i"?Nordion signs agreement with Navidea Biopharmaceuticals.
M2 EQUITYBITES-May 16, 2013-i" Nordion signs agreement with Navidea Biopharmaceuticals(C)2013 M2 COMMUNICATIONS http://www.m2.com
Nordion, a global health science company, has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a company focused on the development and commercialisation of diagnostic and radiopharmaceutical imaging agents for cancer and other diseases.
It was reported yesterday that the contract has been signed for NAV5001, a diagnostic imaging agent utilised to detect Parkinsonian Syndromes and Dementia with Lewy Bodies. NAV5001 manufacturing will help Navidea's Phase 2b and Phase 3 trials, scheduled to start in 2013.
The terms of the contract include two phases, a facility preparation and readiness phase and a clinical trial supply phase.
((Comments on this story may be sent to firstname.lastname@example.org))